VivoSim Labs, Inc. (VIVS) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.23
• Market Cap: $5.35M
• P/E Ratio: 1.17
• EPS: $1.76
• 52-Week High: $9.00
• 52-Week Low: $1.41

Market Sentiment

VivoSim Labs, Inc. currently has a Bullish sentiment score of 0.44.

About VivoSim Labs, Inc.

VivoSim Labs, Inc. is a pioneering biotechnology firm based in San Diego, California, dedicated to revolutionizing disease modeling through the development of advanced 3D tissue technologies. By creating biomimetic tissues that accurately reflect the complexities of human diseases, the company aims to enhance drug discovery, disease understanding, and therapeutic approaches. With a commitment to innovation, VivoSim is positioned to play a critical role in the future of personalized medicine a...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for VivoSim Labs, Inc. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VIVS pay dividends?

VivoSim Labs, Inc. (VIVS) does not currently pay a regular dividend.

What is VIVS's P/E ratio?

VivoSim Labs, Inc. has a price-to-earnings (P/E) ratio of 1.17.

What is VIVS's market cap?

VivoSim Labs, Inc. (VIVS) has a market capitalization of $5.35M with a current stock price of $2.23.